In the group of patients devoid of pneumonia, COPD or heart-related diseases as main diagnosis, NT-proBNP levels ≥6096 ng/L were associated with a two-fold increased risk of in-hospital mortality. This evidence concerns the gene NPPB and susceptibility to pneumonia measurement.